1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. Denmark >
  5. Gilde Healthcare Acquires KLIFO

M&A Deal Summary

Gilde Healthcare Acquires KLIFO

On May 6, 2021, private equity firm Gilde Healthcare acquired life science company KLIFO

Acquisition Highlights
  • This is Gilde Healthcare’s 24th transaction in the Life Science sector.
  • This is Gilde Healthcare’s 4th transaction in Denmark.

M&A Deal Summary
Date 2021-05-06
Target KLIFO
Sector Life Science
Buyer(s) Gilde Healthcare
Deal Type Buyout (LBO, MBO, MBI)

Target

KLIFO

Glostrup, Denmark
KLIFO is a drug development consultancy with significant experience in partnering with biotech and pharmaceutical companies to advance their drug development projects. KLIFO provides end-to-end expert capabilities, enabling partners to maximize opportunity, mitigate risks, drive innovation and achieve efficient project advancement. KLIFO was founded in 1994 and is based in Glostrup, Denmark.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Gilde Healthcare

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1982
PE ASSETS 2.6B EUR
Size Large
Type Sector Focused
DESCRIPTION

Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 1982 and is headquartered in Utrecht, Netherlands.

DEAL STATS #
Overall 48 of 55
Sector: Life Science M&A 24 of 26
Type: Buyout (LBO, MBO, MBI) M&A Deals 9 of 14
Country: Denmark M&A 4 of 4
Year: 2021 M&A 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-27 Acti-Med

Freiensteinau, Germany

Acti-Med is a manufacturer of medical technology. Acti-Med develops, produces, and sells high-quality medical components and devices for medical and pharmaceutical industries. Acti-Med was founded in 1997 and is based in Freiensteinau, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-25 Symeres

Nijmegen, Netherlands

Symeres is a mid-sized European Contract Research Organization for drug discovery and development needs. The company offers best-in-class solutions for drug discovery and drug development for small molecules and beyond. Their services span from preclinical hit finding all the way to the delivery of early clinical phase drug substance API. Symeres blends a deep scientific knowledge base with creativity and problem-solving skills to deliver the quality results that clients need. Symeres is based in Nijmegen, Netherlands.

Sell -
Mergr

Solution for

Product

Company

Legal